Detalles de la búsqueda
1.
Donanemab in Early Alzheimer's Disease.
N Engl J Med
; 384(18): 1691-1704, 2021 05 06.
Artículo
Inglés
| MEDLINE | ID: mdl-33720637
2.
Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease.
Neuroimage
; 256: 119228, 2022 08 01.
Artículo
Inglés
| MEDLINE | ID: mdl-35452806
3.
Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry.
J Geriatr Psychiatry Neurol
; 35(3): 293-301, 2022 05.
Artículo
Inglés
| MEDLINE | ID: mdl-33550928
4.
Discrepancy-Based Evidence for Loss of Thinking Abilities (DELTA): Development and Validation of a Novel Approach to Identifying Cognitive Changes.
J Int Neuropsychol Soc
; 26(5): 464-479, 2020 05.
Artículo
Inglés
| MEDLINE | ID: mdl-31822312
5.
Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward.
Alzheimers Dement
; 16(1): 229-243, 2020 01.
Artículo
Inglés
| MEDLINE | ID: mdl-31914225
6.
Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study.
Alzheimers Dement
; 14(1): 43-53, 2018 01.
Artículo
Inglés
| MEDLINE | ID: mdl-28738187
7.
The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.
Alzheimers Dement
; 13(1): 8-19, 2017 01.
Artículo
Inglés
| MEDLINE | ID: mdl-27583651
8.
Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline.
Alzheimer Dis Assoc Disord
; 27(1): 4-15, 2013.
Artículo
Inglés
| MEDLINE | ID: mdl-23203162
9.
Successful management of severe neuroinvasive eastern equine encephalitis.
Neurocrit Care
; 19(1): 111-5, 2013 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-23733173
10.
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease.
Aging Cell
; 22(8): e13871, 2023 08.
Artículo
Inglés
| MEDLINE | ID: mdl-37291760
11.
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
JAMA Neurol
; 80(12): 1353-1363, 2023 Dec 01.
Artículo
Inglés
| MEDLINE | ID: mdl-37843849
12.
Adding cognition to AT(N) models improves prediction of cognitive and functional decline.
Alzheimers Dement (Amst)
; 13(1): e12174, 2021.
Artículo
Inglés
| MEDLINE | ID: mdl-33816757
13.
Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials.
JAMA Neurol
; 78(4): 445-453, 2021 04 01.
Artículo
Inglés
| MEDLINE | ID: mdl-33587110
14.
Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aß-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay interval.
Alzheimers Res Ther
; 12(1): 31, 2020 03 24.
Artículo
Inglés
| MEDLINE | ID: mdl-32209123
15.
Advancing combination therapy for Alzheimer's disease.
Alzheimers Dement (N Y)
; 6(1): e12073, 2020.
Artículo
Inglés
| MEDLINE | ID: mdl-33043108
16.
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease.
Neuroimage Clin
; 28: 102491, 2020.
Artículo
Inglés
| MEDLINE | ID: mdl-33395982
17.
Quantitative tractography metrics of white matter integrity in diffusion-tensor MRI.
Neuroimage
; 42(2): 568-81, 2008 Aug 15.
Artículo
Inglés
| MEDLINE | ID: mdl-18617421
18.
Real-World Application of Anti-ß-Amyloid Monoclonal Antibodies: Untangling Eligibility.
Neurology
; 101(19): 811-812, 2023 11 07.
Artículo
Inglés
| MEDLINE | ID: mdl-37586880
19.
Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies.
J Alzheimers Dis
; 66(4): 1409-1424, 2018.
Artículo
Inglés
| MEDLINE | ID: mdl-30412493
20.
Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.
J Alzheimers Dis
; 64(3): 689-707, 2018.
Artículo
Inglés
| MEDLINE | ID: mdl-29914022